Dose-Finding Quantitative sigma up 18 Theta -FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies

AKT (a serine/threonine-specific protein kinase) regulates many cellular processes contributing to cytotoxic drug resistance. This study's primary objective examined the relationship between GSK2141795, an oral, pan-AKT inhibitor, and 18F-FDG PET markers of glucose metabolism in tumor tissue to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of nuclear medicine (1978) 2015-12, Vol.56 (12), p.1828-1828
Hauptverfasser:	Gungor, Hatice, Saleem, Azeem, Babar, Syed, Dina, Roberto, El-Bahrawy, Mona A, Curry, Ed, Rama, Nona, Chen, Michele, Pickford, Emily, Agarwal, Roshan, Blagden, Sarah, Carme, Sabin, Salinas, Cristian, Madison, Sam, Krachey, Elizabeth, Santiago-Walker, Ademi, Smith, Deborah A, Morris, Shannon R, Stronach, Euan A, Gabra, Hani
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!